Report - Drug Report - ipsen-pharma.de · Drug Report Nr. 10, 2017 Cabozantinib Multi-Target-Kinase-Inhibitor mit neuarti-gem Wirkspektrum zur Behandlung des fortgeschrittenen Niernomi zkarenl

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form